3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
34
Colonic Neoplasms
18
Rectal Neoplasms
14
Pancreatic Neoplasms
8
Esophageal Neoplasms
7
Adenomatous Polyposis Coli
7
Liver Neoplasms
5
Carcinoma, Hepatocellular
4
Neoplasm Metastasis
3
Turcot syndrome
2
Thymoma
2
Neoplasms
2
Lung Neoplasms
2
Locally Advanced Rectal Cancer
2
Hand-Foot Syndrome
2
Gastrointestinal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma Of Esophagus
2
Thrombocytosis
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polyps
1
Pancreatic Cancer Metastatic
1
Pain, Postoperative
1
Interventions
Irinotecan
4
Oxaliplatin
3
Capecitabine
3
Bevacizumab
3
Surveys and Questionnaires
2
Leucovorin
2
Fluorouracil
2
Drug Therapy
2
Cyclophosphamide
2
Colonoscopy
2
Cetuximab
2
Aspirin
2
repotrectinib
1
pralsetinib
1
pembrolizumab
1
napabucasin
1
lutetium Lu 177 dotatate
1
guadecitabine
1
encorafenib
1
copper dotatate CU-64
1
alectinib
1
Ursodeoxycholic Acid
1
Pemetrexed
1
Oviposition
1
Ocoxin
1
Lutetium-177
1
Lutetium
1
Levoleucovorin
1
KRN-330
1
Folfox protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Intestinal Diseases
×
Celecoxib
×
Gastrointestinal
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled